Literature DB >> 16470377

NKG2D splice variants: a reexamination of adaptor molecule associations.

Brian Rabinovich1, Jennifer Li, Martin Wolfson, William Lawrence, Courtney Beers, Jan Chalupny, Rose Hurren, Brad Greenfield, Richard Miller, David Cosman.   

Abstract

NKG2D is a homodimeric C-type lectin-related receptor expressed on natural killer (NK) cells and T cells. In mice, alternative deoxyribonucleic acid (DNA) splicing generates two isoforms of NKG2D that differ in the length of their cytoplasmic domains. Their ability to induce cellular activation is mediated via association with two membrane-bound, signaling adaptor molecules, DAP10 and DAP12. It has been reported that the long form of NKG2D associates exclusively with DAP10, whereas the short variant can interact with either adaptor. The short isoform was reported to be almost undetectable in naive NK cells. Using two distinct cell types, we demonstrate that like the short isoform, the long variant of NKG2D also associates not only with DAP10 but also with DAP12. Using reporter cells (70Z/3), we demonstrate that DAP12 can compete equally with DAP10 for association with both variants of NKG2D when DAP10 and DAP12 are coexpressed. Cross-linking either isoform of NKG2D induces a calcium flux when associated exclusively with DAP10 or DAP12. Moreover, using quantitative polymerase chain reaction (PCR), we also show that the short isoform of NKG2D is expressed in naive NK cells. Our data suggest that signaling via mouse NKG2D isoforms is more complex than originally presented.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16470377     DOI: 10.1007/s00251-005-0078-x

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  25 in total

1.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

Authors:  G B Cohen; R T Gandhi; D M Davis; O Mandelboim; B K Chen; J L Strominger; D Baltimore
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

2.  An activating immunoreceptor complex formed by NKG2D and DAP10.

Authors:  J Wu; Y Song; A B Bakker; S Bauer; T Spies; L L Lanier; J H Phillips
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

3.  Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.

Authors:  Leonidas N Carayannopoulos; Olga V Naidenko; Daved H Fremont; Wayne M Yokoyama
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

4.  Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.

Authors:  Lauren I Richie Ehrlich; Kouetsu Ogasawara; Jessica A Hamerman; Rayna Takaki; Alessandra Zingoni; James P Allison; Lewis L Lanier
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

Review 5.  NKG2D in innate and adaptive immunity.

Authors:  Lewis L Lanier
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

6.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.

Authors:  V Groh; R Rhinehart; J Randolph-Habecker; M S Topp; S R Riddell; T Spies
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

7.  Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D.

Authors:  Andreas Diefenbach; Elena Tomasello; Mathias Lucas; Amanda M Jamieson; Jennifer K Hsia; Eric Vivier; David H Raulet
Journal:  Nat Immunol       Date:  2002-11-11       Impact factor: 25.606

8.  A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

Authors:  Sophie Hüe; Jean-Jacques Mention; Renato C Monteiro; ShaoLing Zhang; Christophe Cellier; Jacques Schmitz; Virginie Verkarre; Nassima Fodil; Seiamak Bahram; Nadine Cerf-Bensussan; Sophie Caillat-Zucman
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

9.  NKG2D blockade prevents autoimmune diabetes in NOD mice.

Authors:  Kouetsu Ogasawara; Jessica A Hamerman; Lauren R Ehrlich; Helene Bour-Jordan; Pere Santamaria; Jeffrey A Bluestone; Lewis L Lanier
Journal:  Immunity       Date:  2004-06       Impact factor: 31.745

10.  Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.

Authors:  Pascale André; Roberta Castriconi; Marion Espéli; Nicolas Anfossi; Tiffany Juarez; Sophie Hue; Holli Conway; François Romagné; Alessandra Dondero; Marina Nanni; Sophie Caillat-Zucman; David H Raulet; Cristina Bottino; Eric Vivier; Alessandro Moretta; Pascale Paul
Journal:  Eur J Immunol       Date:  2004-04       Impact factor: 5.532

View more
  13 in total

1.  Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action.

Authors:  Jingxiong Wang; Sui Zhang; Brian Rabinovich; Luc Bidaut; Suren Soghomonyan; Mian M Alauddin; James A Bankson; Elizabeth Shpall; James T Willerson; Juri G Gelovani; Edward T H Yeh
Journal:  Circ Res       Date:  2010-05-06       Impact factor: 17.367

2.  Molecular imaging of mesenchymal stem cell: mechanistic insight into cardiac repair after experimental myocardial infarction.

Authors:  Jingxiong Wang; Amer Najjar; Sui Zhang; Brian Rabinovich; James T Willerson; Juri G Gelovani; Edward T H Yeh
Journal:  Circ Cardiovasc Imaging       Date:  2011-12-01       Impact factor: 7.792

3.  Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation.

Authors:  Jérôme Giustiniani; Armand Bensussan; Anne Marie-Cardine
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

4.  An unfolded protein-induced conformational switch activates mammalian IRE1.

Authors:  G Elif Karagöz; Diego Acosta-Alvear; Hieu T Nguyen; Crystal P Lee; Feixia Chu; Peter Walter
Journal:  Elife       Date:  2017-10-03       Impact factor: 8.140

5.  Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12.

Authors:  Masanori Inui; Yuki Kikuchi; Naoko Aoki; Shota Endo; Tsutomu Maeda; Akiko Sugahara-Tobinai; Shion Fujimura; Akira Nakamura; Atsushi Kumanogoh; Marco Colonna; Toshiyuki Takai
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-27       Impact factor: 11.205

6.  CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway.

Authors:  Elisabet Ampudia-Mesias; Francisco Puerta-Martinez; Miurel Bridges; David Zellmer; Andrew Janeiro; Matt Strokes; Yuk Y Sham; Ayman Taher; Maria G Castro; Christopher L Moertel; G Elizabeth Pluhar; Michael R Olin
Journal:  Neurotherapeutics       Date:  2021-04-07       Impact factor: 6.088

7.  An inducible, isogenic cancer cell line system for targeting the state of mismatch repair deficiency.

Authors:  Julie M Bailis; Marcia L Gordon; Jesse L Gurgel; Alexis C Komor; Jacqueline K Barton; Ilan R Kirsch
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

Review 8.  NKG2D Ligands in Tumor Immunity: Two Sides of a Coin.

Authors:  Jinyu Zhang; Fahmin Basher; Jennifer D Wu
Journal:  Front Immunol       Date:  2015-03-04       Impact factor: 7.561

9.  Continuous engagement of a self-specific activation receptor induces NK cell tolerance.

Authors:  Sandeep K Tripathy; Peter A Keyel; Liping Yang; Jeanette T Pingel; Tammy P Cheng; Achim Schneeberger; Wayne M Yokoyama
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307

Review 10.  Complexity and Diversity of the NKR-P1:Clr (Klrb1:Clec2) Recognition Systems.

Authors:  Christina L Kirkham; James R Carlyle
Journal:  Front Immunol       Date:  2014-06-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.